LAGUNA HILLS, Calif., April 24, 2018 – /Globe Newswire/ – With Root Canal Awareness Week just eleven days away, Sonendo®, the developer of the GentleWave® System, has achieved a significant milestone by shipping more than 50,000 GentleWave Procedure Instruments to endodontists in the United States.
The timing of the achievement, is notable, given the proximity to both the upcoming US consumer Root Canal Awareness Week, 6-12 May 2018, and the American Association of Endodontists (AAE) annual meeting which will take place this week, 25-28 April 2018, in Denver, Colorado.
About this milestone, Bjarne Bergheim, President & CEO of Sonendo, stated, “We are excited by the market response to the GentleWave System - both from patients and endodontists alike. We look forward to sharing more exciting results at this year’s AAE annual meeting.”
According to an AAE survey, patient apprehension about getting a standard root canal remains high. The GentleWave Procedure continues to receive positive testimonials from patients pleased with their results and likely to recommend the procedure to friends and family who may need a root canal.
Sonendo, Inc. is a privately-held, venture-backed company developing innovative and disruptive technologies to transform dentistry by Saving Teeth Through Sound Science. The first commercially available product from Sonendo, the GentleWave System, available in the US, shows significant improvements in clinical efficacy and treatment efficiency when compared to standard root canal techniques.1,2 For more information, please visit www.sonendo.com.
1 Sigurdsson A et al. (2016) J Endod. 42:1040-48. 2 Molina B et al. (2015) J Endod. 41:1701-05.
This announcement contains forward-looking statements based on management's beliefs, assumptions and expectations and information currently available to management. All statements that address events or developments that we expect or anticipate will occur in the future are forward-looking statements, including without limitation our expectations on the timing and progress of research and development activities. Management believes that these forward-looking statements are reasonable as and when made. However, you should not place undue reliance on forward-looking statements because they speak only as of the date when made. Sonendo does not assume any obligation to update or revise any forward-looking statements publicly, whether as a result of new information, future events or otherwise. Actual results, developments or events could differ materially from those disclosed in the forward-looking statements.